Cambridge Mask Co. ramps production to help combat coronavirus epidemic
Face masks made by a Cambridge company and based on military-standard technology have triggered a massive ramp-up in production worldwide as customers cumulatively try to order millions of them to counter the threat of the coronavirus.
Cambridge scale-ups make Tech Nation growth programme
Cambridge duo ThoughtRiver and Eagle Genomics have been chosen for Tech Nation’s Upscale 5.0 programme for the UK’s most exciting and fastest growing scale-up technology companies.
Wazoku makes two senior hires as the idea management scaleup prepares itself for further growth in 2020
Idea management scaleup Wazoku has made two new senior hires, as the company readies itself for further growth in 2020. Kathryn Layland joins as Chief Revenue Officer (CRO) based in Wazoku’s London HQ, while Alex Butucea arrives as Wazoku’s new Director of Software Engineering, in the company’s Bristol office.
Researchers find cancer-fighting potential in non-cancer drugs
(Reuters Health) – U.S. researchers who tested the cancer-fighting properties of more than 4,500 non-cancer drugs found nearly 50 drugs for other conditions showed at least some cancer-killing ability.
Biofuels company appoints new chief executive
Teesside-based biofuels company Nova Pangaea Technologies has appointed a new chief executive, who is tasked with leading the commercialisation of the business.
Eye drops for retinal vascular diseases to be developed by Exonate and Jannssen
Duxford company Exonate is to collaborate with Jannssen Pharmaceuticals to develop an eye drop treatment to help change the lives of those with vision loss.
Exonate Announces Collaboration With Janssen
The program, facilitated by Johnson & Johnson Innovation, has the potential to improve the treatment of patients with retinal vascular diseases and transform the lives of those suffering from vision loss.
PhoreMost enlists Otsuka in multi-project drug discovery collab
UK-based PhoreMost has announced that it has entered into a multi-project collaboration with Otsuka Pharmaceutical, a company dedicated to the research and development of highly-innovative drugs and diagnostics.
Anderson hands Bango CEO reins to Larbey
Paul Larbey is taking over as CEO of Cambridge mobile commerce company Bango in a development that sees the company founder Ray Anderson take on the role of executive chair.
Controllis introduces a family of high capacity rectifiers with seamless solar integration and prioritisation capability
Telecoms operators can easily upgrade their power networks and incorporate solar energy for greater reliability and greener power
Foresight Williams Backs Rovco
Subsea technology firm Rovco has secured a £3.9 million investment from Foresight group via the Foresight Williams Technology EIS Fund and Foresight VCTs.
Rovco raises £5 million Series A Investment
Rovco, the subsea robotics company, has announced a £3.9 million Series A investment from Foresight group. The investment is part of a larger round totalling £5 million which included funds from existing shareholders. Rovco provides some of the world’s most detailed remote hydrographic surveys using robotics, 3D and Artificial Intelligence. Rovco’s products are used for […]
Hikma and Arecor announce exclusive agreement to develop and commercialise ready-to-use medicine using Arestat™ technology
Hikma Pharmaceuticals PLC, the multinational generic pharmaceutical company, and Arecor Ltd, the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announce they have entered into an exclusive agreement to co-develop a new, ready-to-use injectable medicine in the US through Hikma’s affiliate, Hikma Pharmaceuticals USA Inc.
#21toWatch in 2020 - nine trailblazers on Cofinitive’s longlist revealed
We are delighted to feature nine of the longlisted companies on the innovative #21toWatch campaign and awards run by corporate communications consultancy Cofinitive.
PhoreMost and Boehringer Ingelheim in multi-project drug discovery alliance
Cambridge biopharma business PhoreMost has entered into a multi-project drug discovery collaboration with Boehringer Ingelheim, one of the world-leading pharmaceutical companies developing innovative therapies for diseases with unsatisfactory treatments.
Government to fund building of bio fuel production plants
Orange peel, rubbish and fatbergs will be amongst the unlikely components used by four UK-based plants to produce green fuels with support from government funding.
Ieso Digital Health launches one-to-one appointment system for Step 2 mental health patients
A busy period for Ieso Digital Health has continued with the launch of a new one-to-one appointment system to help reduce waiting lists for NHS mental healthcare patients.
Catching Up with Tripism CEO Adam Kerr
Tripism once was known as the personalization poster child of Microsoft's travel program. It's matured since then. The platform has registered 1 million travelers and serves as an engagement platform that brings travelers, travel managers and suppliers together in a virtuous data cycle that benefits every participant, according to CEO Adam Kerr. He spoke this week with BTN editor-in-chief Elizabeth West.
Ieso Digital Health to trial online therapy tailored for diabetes patients
A Cambridge company has launched a clinical trial to measure the success of online cognitive behavioural therapy tailored for those with with type 2 diabetes.
Healx and Boehringer battle rare neurological diseases
Cambridge-based Healx and German powerhouse Boehringer Ingelheim have joined forces to identify indications related to rare neurological diseases.